MX378875B - Metodo para preparar penams. - Google Patents

Metodo para preparar penams.

Info

Publication number
MX378875B
MX378875B MX2016014644A MX2016014644A MX378875B MX 378875 B MX378875 B MX 378875B MX 2016014644 A MX2016014644 A MX 2016014644A MX 2016014644 A MX2016014644 A MX 2016014644A MX 378875 B MX378875 B MX 378875B
Authority
MX
Mexico
Prior art keywords
penams
preparing
methylpenam
reacted
derivatives
Prior art date
Application number
MX2016014644A
Other languages
English (en)
Spanish (es)
Other versions
MX2016014644A (es
Inventor
Andrea Faini
Giovanni Fogliato
Marco Forzatti
Stefano Biondi
Original Assignee
Allecra Therapeutics Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Sas filed Critical Allecra Therapeutics Sas
Publication of MX2016014644A publication Critical patent/MX2016014644A/es
Publication of MX378875B publication Critical patent/MX378875B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87—Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
MX2016014644A 2014-05-15 2015-05-14 Metodo para preparar penams. MX378875B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1408649.0A GB201408649D0 (en) 2014-05-15 2014-05-15 Method
PCT/EP2015/060733 WO2015173378A2 (en) 2014-05-15 2015-05-14 Method

Publications (2)

Publication Number Publication Date
MX2016014644A MX2016014644A (es) 2017-02-23
MX378875B true MX378875B (es) 2025-03-11

Family

ID=51134924

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014644A MX378875B (es) 2014-05-15 2015-05-14 Metodo para preparar penams.

Country Status (29)

Country Link
US (1) US9963465B2 (enExample)
EP (3) EP3143028B1 (enExample)
JP (1) JP6613303B2 (enExample)
KR (1) KR102329186B1 (enExample)
CN (1) CN106459086B (enExample)
AU (1) AU2015261416B2 (enExample)
BR (1) BR112016026074B1 (enExample)
CA (1) CA2945900C (enExample)
CL (2) CL2016002880A1 (enExample)
CR (1) CR20160580A (enExample)
CY (2) CY1120957T1 (enExample)
DK (2) DK3143028T3 (enExample)
EA (2) EA201991629A3 (enExample)
EC (1) ECSP16085143A (enExample)
ES (2) ES2725675T3 (enExample)
GB (1) GB201408649D0 (enExample)
HR (2) HRP20182065T1 (enExample)
HU (1) HUE044511T2 (enExample)
IL (1) IL248834B (enExample)
LT (2) LT3231806T (enExample)
MX (1) MX378875B (enExample)
PE (1) PE20161433A1 (enExample)
PL (2) PL3143028T3 (enExample)
PT (2) PT3231806T (enExample)
RS (2) RS58748B1 (enExample)
SG (1) SG11201609494YA (enExample)
SI (2) SI3231806T1 (enExample)
TR (1) TR201906867T4 (enExample)
WO (1) WO2015173378A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319776A (en) 1969-07-15 1973-06-06 Yorkshire Chemicals Ltd Basic dyes
WO2008010048A2 (en) * 2006-07-12 2008-01-24 Orchid Chemicals & Pharmaceuticals Limited Novel 2-substituted methyl penam derivatives
EA030662B1 (ru) * 2010-11-25 2018-09-28 Аллекра Терапойтикс Гмбх β-ЛАКТАМОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ β-ЛАКТАМАЗЫ И ИХ ПРИМЕНЕНИЕ
KR20120067257A (ko) * 2010-12-15 2012-06-25 서강대학교산학협력단 3-메틸-1,4-치환된 1,2,3-트라이아졸륨 기반의 이온성 액체 및 그의 제조방법과 응용

Also Published As

Publication number Publication date
ES2699644T3 (es) 2019-02-12
CA2945900A1 (en) 2015-11-19
CN106459086A (zh) 2017-02-22
SG11201609494YA (en) 2016-12-29
PL3143028T3 (pl) 2019-04-30
CL2016002880A1 (es) 2017-06-16
EA201692306A1 (ru) 2017-05-31
JP6613303B2 (ja) 2019-11-27
EA201991629A3 (ru) 2020-02-28
EP3231806A1 (en) 2017-10-18
IL248834B (en) 2019-05-30
WO2015173378A2 (en) 2015-11-19
PT3143028T (pt) 2018-12-17
EP3231806B1 (en) 2019-02-13
PE20161433A1 (es) 2017-01-18
KR102329186B1 (ko) 2021-11-22
AU2015261416B2 (en) 2019-07-11
US9963465B2 (en) 2018-05-08
HRP20190830T1 (hr) 2019-06-28
HRP20182065T1 (hr) 2019-02-08
GB201408649D0 (en) 2014-07-02
EP3441395A1 (en) 2019-02-13
BR112016026074A8 (pt) 2021-03-30
CR20160580A (es) 2017-05-09
HUE044511T2 (hu) 2019-10-28
CY1121756T1 (el) 2020-07-31
EP3143028B1 (en) 2018-09-26
NZ725121A (en) 2023-09-29
ES2725675T3 (es) 2019-09-26
WO2015173378A3 (en) 2016-01-14
CA2945900C (en) 2023-01-24
EA201991629A2 (ru) 2019-12-30
TR201906867T4 (tr) 2019-05-21
KR20170002466A (ko) 2017-01-06
US20170101421A1 (en) 2017-04-13
DK3231806T3 (da) 2019-05-20
JP2017515907A (ja) 2017-06-15
RS58430B1 (sr) 2019-04-30
RS58748B1 (sr) 2019-06-28
LT3143028T (lt) 2018-12-27
PT3231806T (pt) 2019-05-30
LT3231806T (lt) 2019-05-27
EA033494B1 (ru) 2019-10-31
EP3143028A2 (en) 2017-03-22
CL2018001961A1 (es) 2018-08-31
CN106459086B (zh) 2018-11-13
AU2015261416A1 (en) 2016-11-10
ECSP16085143A (es) 2017-05-31
SI3143028T1 (sl) 2019-01-31
PL3231806T3 (pl) 2019-08-30
MX2016014644A (es) 2017-02-23
BR112016026074B1 (pt) 2023-01-03
DK3143028T3 (da) 2019-01-02
SI3231806T1 (sl) 2019-06-28
CY1120957T1 (el) 2019-12-11
IL248834A0 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
PE20171094A1 (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia linfoblastica aguda
PL3519420T3 (pl) Cykliczne związki dinukleotydowe
MX2015016535A (es) Metodo de produccion para tagatosa.
SG11201609204XA (en) Method of producing organic compounds
TW201615060A (en) Organic light emitting device
FR3003403B1 (fr) Procede de formation de diodes electroluminescentes
GB201700642D0 (en) Reverse cementation of liner string for formation stimulation
BR112017013029A2 (pt) síntese comercialmente viável de cantaridina e de-rivados de cantaridina bioativos
MX2017006200A (es) Procesos e intermediarios para preparar dialcano eteres terminados con acido a, ?-dicarboxilico.
BR112017002139A2 (pt) ?método para preparar um composto?
DOP2016000142A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
MX382659B (es) Proceso para la preparación de derivados de tiazol.
KR102317267B9 (ko) 유기 발광 표시 소자
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
GT201600117A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
ECSP16024805A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
GB201509968D0 (en) Light-emitting diode bulb
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2016016397A (es) Proceso para preparar 3-cloro-2-vinilfenol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
EP3144984A4 (en) Method for manufacturing light-emitting diode package
CR20150484A (es) Método de producción de compuestos de piridazinona
TWM489377U (en) Package structure of organic light-emitting diode
GB201713864D0 (en) Organic synthetic intermediate hexanoic acid synthesis method
AR105955A1 (es) Método para producir una piridinacarboxamida